What it is
Peptidoglycan is the cell wall of bacteria. A 2008 review by Vollmer, Blanot and de Pedro describes it as "a unique and essential structural element in the cell wall of most bacteria" (FEMS Microbiology Reviews, PMID 18194336). It has two ingredients, and its name lists both:
- glycan — long strands of sugars;
- peptide — short chains of a few amino acids that cross-link the strands.
Linked together, they form one continuous mesh, the sacculus, wrapped around the cell membrane like a closed bag. The peptides are not the same everywhere: the review records high diversity in their composition and sequence between species, and changes in the fine structure with growth conditions.
What the mesh is made of
A 2010 review of the bacterial envelope by Silhavy, Kahne and Walker (Cold Spring Harbor Perspectives in Biology, PMID 20452953) gives the building block: a repeating pair of sugars, N-acetylglucosamine and N-acetylmuramic acid, with pentapeptide side chains — five-amino-acid stems — that cross-link one strand to the next. The finished sacculus is, in the review's words, one very large polymer that can be isolated and seen under a light microscope. It is rigid enough to fix the cell's shape, and it is the reason bacteria do not burst when placed in distilled water.
Gram-positive and Gram-negative: a difference in thickness
In 1884 Christian Gram devised the stain that still sorts nearly all bacteria into two groups. The same review gives the structural reason it works:
| Gram-negative | Gram-positive | |
|---|---|---|
| Peptidoglycan thickness | A few nanometres | 30–100 nm |
| Layers | One to a few | Many |
| Outside the wall | An outer membrane containing lipopolysaccharide | No outer membrane; long anionic polymers (teichoic acids) thread through the layers |
The review adds that Gram-positive species differ among themselves most in the peptide cross-links between glycan strands — the same species-to-species variation the 2008 review describes.
Why it is not a supplement
This library mostly records peptides people take or are prescribed. Peptidoglycan is in it for the opposite reason: people search the word because it contains "peptide", and it is nothing of that kind. Humans do not make it, it is not sold as a product, and no approved medicine contains it. The peptide-chain entry and the peptide-bond entry explain the chemistry the two share — amino acids joined by peptide bonds — and nothing more.
Why it matters to medicine
Because people do not make peptidoglycan and most bacteria cannot live without it, its construction is a target:
| Who acts on it | What the source says |
|---|---|
| Penicillin G | Acts by inhibiting biosynthesis of cell-wall mucopeptide — an older name for peptidoglycan (penicillin G potassium label, effective 2025-01-28) |
| Vancomycin | Its bactericidal action results primarily from inhibition of cell-wall biosynthesis (vancomycin hydrochloride injection label, Gland Pharma, effective 2026-01-30) |
| Lysozyme (the body's own enzyme) | A 148-residue human enzyme in tissues and body fluids, annotated as primarily bacteriolytic; its recorded reaction is hydrolysis of the (1→4)-beta links between N-acetylmuramic acid and N-acetylglucosamine in peptidoglycan, EC 3.2.1.17 — it cuts the sugar backbone, not the peptides (UniProt P61626) |
A newer antibiotic in the same family as vancomycin is precise about the target: the lipoglycopeptide dalbavancin binds the D-alanyl-D-alanine end of the peptide stems and so blocks cross-linking (Dalvance label). The body's own antibacterial peptides, such as LL-37, are a separate line of defence and are recorded in their own entries.
Where it stands
PubMed returns 19,091 records for peptidoglycan, only 16 tagged as randomised controlled trials (2026-10-04) — a microbiology subject, not a treatment one. Physical measurements of its thickness, elasticity and porosity are, in the 2008 review's words, limited.
Related reading
For what a peptide is and how short chains are named, see what peptides are. For the human antimicrobial peptide most often discussed online, see LL-37; for the cyclic peptide in over-the-counter first-aid ointment, see the bacitracin entry.
